Advanced search
Publication Cover
Biomarkers in Medicine Volume 3, 2009 - Issue 3
Submit an article Journal homepage
205
Views
0
CrossRef citations to date
0
Altmetric
Review

Combining Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry in Biomarker Discovery

GA Nagana Gowda1 Analytical Division, Department of Chemistry,Purdue University,West Lafayette,IN 47907,USA.Correspondence[email protected] [email protected]
[email protected] [email protected]
,
Omkar B Ijare2 NRC Institute for Biodiagnostics,Winnipeg, Manitoba,Canada
,
Narasimhamurthy Shanaiah1 Analytical Division, Department of Chemistry,Purdue University,West Lafayette,IN 47907,USA.
&
Tedros Bezabeh2 NRC Institute for Biodiagnostics,Winnipeg, Manitoba,Canada
Pages 307-322 | Published online: 02 Jun 2009

Bibliography

  • Wishart DS : Metabolomics: the principles and potential applications to transplantation.Am. J. Transplant.5(12), 2814–2820 (2005).
  • Nicholson JK , LindonJC: Systems biology: metabonomics.Nature455(7216), 1054–1056 (2008).
  • Wishart DS , KnoxC, GuoACet al.: HMDB: a knowledgebase for the human metabolome.Nucleic Acids Res.37(database issue), D603–D610 (2009).
  • Pasikanti KK , HoPC, ChanEC: Gas chromatography/mass spectrometry in metabolic profiling of biological fluids.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871(2), 202–211 (2008).
  • Nagana Gowda GA , ZhangS, GuH, AsiagoV, ShanaiahN, RafteryD: Metabolomics-based methods for early disease diagnostics.Expert. Rev. Mol. Diagn.8(5), 617–633 (2008).
  • Raftery D , Nagana GowdaGA: An approaching new wave of multicomponent biomarker diagnostics?J. Urol.179(6), 2089–2090 (2008).
  • Holmes E , WilsonID, NicholsonJK: Metabolic phenotyping in health and disease.Cell134(5), 714–717 (2008).
  • Beckonert O , KeunHC, EbbelsTMet al.: Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.Nat. Protoc.2(11), 2692–2703 (2007).
  • Wu DH , ChenAD, JohnsonCS: An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses.J. Magn. Reson. Series A115(2), 260–264 (1995).
  • Dumas ME , CanletC, AndréF, VercauterenJ, ParisA: Metabonomic assessment of physiological disruptions using 1H-13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables.Anal. Chem.74(10), 2261–2273 (2002).
  • Tang HR , WangY, NicholsonJK, LindonJC: Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma.Anal. Biochem.325(2), 260–272 (2004).
  • Xi Y , de RoppJS, ViantMR, WoodruffDL, YuP: Automated screening for metabolites in complex mixtures using 2D COSY NMR spectroscopy. Metabolomics2(4), 221–233 (2006).
  • Viant MR : Improved methods for the acquisition and interpretation of NMR metabolomic data.Biochem. Biophys. Res. Commun.310(3), 943–948 (2003).
  • Xi Y , de RoppJS, ViantMR, WoodruffDL, YuP: Improved identification of metabolites in complex mixtures using HSQC NMR spectroscopy. Anal. Chim. Acta614(2), 127–133 (2008).
  • Duarte IF , Legido-QuigleyC, ParkerDAet al.: Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.Mol. Biosyst.5(2), 180–190 (2009).
  • Spraul M , FreundAS, NastRE, WithersRS, MaasWE, CorcoranO: Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: application to the analysis of acetaminophen metabolites in urine.Anal. Chem.75(6), 1536–1541(2003).
  • Olson DL , PeckTL, WebbAG, MaginRL, SweedlerJV: High-resolution microcoil 1H-NMR for mass-limited, nanoliter-volume samples.Science270(5244), 1967–1970 (1995).
  • Webb AG : Microcoil nuclear magnetic resonance spectroscopy.J. Pharm. Biomed. Anal.38(5), 892–903 (2005).
  • Shanaiah N , DesilvaMA, Nagana GowdaGA, RafteryMA, HainlineBE, RafteryD: Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR. Proc. Natl Acad. Sci. USA104(28), 11540–11544 (2007).
  • Ye T , MoH, ShanaiahN, Nagana GowdaGA, ZhangS, RafteryD: Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolites. Anal. Chem. (2009) (In Press).
  • Lindon JC , HolmesE, NicholsonJK: Metabonomics techniques and applications to pharmaceutical research and development.Pharm. Res.23(6), 1075–1088 (2006).
  • Kind T , TolstikovV, FiehnO, WeissRH: A comprehensive urinary metabolomic approach for identifying kidney cancer.Anal. Biochem.363(2), 185–195 (2007).
  • Wilson ID , NicholsonJK, Castro-PerezJet al.: High resolution ‘ultra performance‘ liquid chromatography coupled to OA-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.J. Proteome Res.4(2), 591–598 (2005).
  • van der Greef J , SmildeAK: Symbiosis of chemometrics and metabolomics: past, present, and future.J. Chemometrics19(5–7), 376–386 (2005).
  • Brown SC , KruppaG, DasseuxJL: Metabolomics applications of FT-ICR mass spectrometry.Mass Spectrom. Rev.24(2), 223–231(2005).
  • Granger JH , BakeA, PlumbRSet al.: Ultra performance liquid chromatography-MS(TOF): New separations technology for high throughput metabonomics.Drug Met. Rev.36(2), 252–252 (2004).
  • Villas-Boas SG , MasS, AkessonM, SilasG, SmedsgaardJ, NielsenJ: Mass spectrometry in metabolome analysis.Mass Spectrom. Rev.24(5), 613–646 (2005).
  • Zhang X , WeiD, YapY, LiL, GuoS, CheneF: Mass spectrometry-based ‘omics‘ technologies in cancer diagnostics.Mass Spectrom. Rev.26(3), 403–431(2007).
  • Mohler RE , DombekKM, HoggardJC, YoungET, SynovecRE: Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells.Anal. Chem.78(8), 2700–2709 (2006).
  • O‘Hagan S , DunnWB, KnowlesJDet al.: Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics.Anal. Chem.79(2), 464–476(2007).
  • Zhang Z , ShahB: Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.Anal. Chem.79(15), 5723–5729 (2007).
  • Ojanperä S , PelanderA, PelzingM, KrebsI, VuoriE, OjanperäI: Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry.Rapid Commun. Mass Spectrom.20(7), 1161–1167 (2006).
  • Lenz EM , WilsonID: Analytical strategies in metabonomics.J. Proteome Res.6(2), 443–458 (2007).
  • Takáts Z , WisemanJM, GologanB, CooksRG: Mass spectrometry sampling under ambient conditions with desorption electrospray ionization.Science306(5695), 471–473 (2004).
  • Chen H , VenterA, CooksRG: Extractive electrospray ionization for direct analysis of undiluted urine, milk and other complex mixtures without sample preparation.Chem. Commun.19, 2042–2044 (2006).
  • Cody RB , LarameeJA, DurstHD: Versatile new ion source for the analysis of materials in open air under ambient conditions.Anal. Chem.77(8), 2297–2302 (2005).
  • Goodacre R , BroadhurstD, SmildeAKet al.: Proposed minimum reporting standards for data analysis in metabolomics.Metabolomics3(3), 231–241(2007).
  • Lee KR , LinX, ParkDC, EslavaS: Megavariate data analysis of mass spectrometric proteomics data using latent variable projection method.Proteomics3(9), 1680–1686 (2003).
  • Beckonert O , BollardME, EbbelsTMDet al.: NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches.Anal. Chim. Acta490(1), 3–15(2003).
  • Somorjai RL , DolenkoB, DemkoAet al.: Mapping high-dimensional data onto a relative distance plane – an exact method for visualizing and characterizing high-dimensional patterns.J. Biomed. Inform.37(5), 366–379 (2004).
  • Mahadevan S , ShahSL, MarrieTJ, SlupskyCM: Analysis of metabolomic data using support vector machines.Anal. Chem.80(19), 7562–7570 (2008).
  • Wold H : Partial least squares. In: Encyclopedia of Statistical Sciences (Volume 6). Kotz S, Johnson NL (Eds). Wiley, NY, USA, 581–591 (1985).
  • Barker M , RayensW: Partial least squares for discrimination.J. Chemometrics17(3), 166–173 (2003).
  • Trygg J , HolmesE, LundstedtT: Chemometrics in metabonomics.J. Proteome Res.6(2), 469–479 (2007).
  • Hai-Lei M , MinX, BinW, Hui-MinW, Xiao-MingD, Dong-HaiL: Evaluation of filtering effects of orthogonal signal correction on metabonomic analysis of healthy human serum 1H NMR spectra.Acta. Chim. Sinica65(2), 152–158 (2007).
  • Trygg J , WoldS: Orthogonal projections to latent structures (O-PLS).J. Chemometrics16(3), 119–128 (2003).
  • Rantalainen M , CloarecO, BeckonertOet al.: Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.J. Proteome Res.5(10), 2642–2655(2006).
  • Werner E , HeilierJF, DucruixC, EzanE, JunotC, TabetJC: Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871(2), 143–163 (2008).
  • Blow N : Metabolomics: Biochemistry‘s new look.Nature455(7213), 697–700 (2008).
  • Wishart DS , LewisMJ, MorrisseyJAet al.: The human cerebrospinal fluid metabolome.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871(2), 164–173 (2008).
  • Yang Y , LiC, NieXet al.: Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.J. Proteome Res.6(7), 2605–2614 (2007).
  • Chan EC , KohPK, MalMet al.: Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).J. Proteome Res.8(1), 352–361 (2009).
  • Yang C , RichardsonAD, SmithJW, OstermanA: Comparative metabolomics of breast cancer.Pac. Symp. Biocomput.181–192 (2007).
  • Chen H , PanZ, TalatyN, RafteryD, CooksRG: Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation.Rapid Commun. Mass Spectrom.20(10), 1577–1584 (2006).
  • Pan Z , GuH, TalatyNet al.: Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism.Anal. Bioanal. Chem.387(2), 539–549 (2007).
  • Williams RE , LenzEM, EvansJAet al.: A combined 1H NMR and HPLC–MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats.J. Pharm. Biomed. Anal.38(3), 465–471 (2005).
  • Williams RE , LenzEM, LowdenJS, RantalainenM, WilsonID: The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS.Mol. Biosyst.1(2), 166–175 (205).
  • Gu H , ChenH, PanZet al.: Monitoring diet effects via biofluids and their implications for metabolomics studies.Anal. Chem.79(1), 89–97 (2007).
  • Crockford DJ , MaherAD, AhmadiKRet al.: 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies.Anal. Chem.80(18), 6835–6844 (2008).
  • Sidelmann UG , Bj⊘rnsdottirI, ShockcorJP, HansenSH, LindonJC, NicholsonJK: Directly coupled HPLC-NMR and HPLC-MS approaches for the rapid characterisation of drug metabolites in urine: application to the human metabolism of naproxen.J. Pharm. Biomed. Anal.24(4), 569–579 (2001).
  • Payne GS , Dzik-JuraszAS, ManciniL, NutleyB, RaynaudF, LeachMO: Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry.Cancer Chemother. Pharmacol.56(4), 409–414 (2005).
  • Shockcor JP , UngerSE, WilsonID, FoxallPJ, NicholsonJK, LindonJC: Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine.Anal. Chem.68(24), 4431–4435 (1996).
  • Sun J , SchnackenbergLK, HollandRDet al.: Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871(2), 328–340 (2008).
  • Lenz EM , BrightJ, KnightRet al.: Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat.Biomarkers10(2–3), 173–187 (2005).
  • Crockford DJ , HolmesE, LindonJCet al.: Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies.Anal. Chem.78(2), 363–371 (2006).
  • Lenz EM , BrightJ, KnightR, WilsonID, MajorH: A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity.Analyst129(6), 535–541 (2004).
  • Xue R , LinZ, DengCet al.: A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.Rapid Commun. Mass Spectrom.22(19), 3061–3068 (2008).
  • Xue R , DongL, ZhangSet al.: Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry.Rapid Commun. Mass Spectrom.22(8), 1181–1186 (2008).
  • Wang Y , WangT, ShiXet al.: Analysis of acetylcholine, choline and butyrobetaine in human liver tissues by hydrophilic interaction liquid chromatography-tandem mass spectrometry.J. Pharm. Biomed. Anal.47(4–5), 870–875 (2008).
  • Mendoza ME , MonteMJ, El-MirMY, BadiaMD, MarinJJ: Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis.Clin. Sci.102(2), 143–150 (2002).
  • Khan SA , CoxIJ, HamiltonG, ThomasHC, Taylor-RobinsonSD: In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.Liver Int.25(2), 273–281 (2005).
  • Cox IJ , SharifA, CobboldJF, ThomasHC, Taylor-RobinsonSD: Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.World J. Gastroenterol.12(30), 4773–4783 (2006).
  • Soper R , HimmelreichU, PainterDet al.: Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy.Pathology34(5), 417–422 (2002).
  • Griffitts J , TesiramYA, ReidGE, SaundersD, FloydRA, TownerRA: In vivo magnetic resonance spectroscopy (MRS) assessment of altered fatty acyl unsaturation in liver tumor formation of a TGFα/c-myc transgenic mouse model.J. Lipid Res.50(4), 611–622 (2009).
  • Nishijima T , NishinaM, FujiwaraK: Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary diseases: its utility in detection of malignancies.Jpn. J. Clin. Oncol.27(1), 13–17 (1997).
  • Nagana Gowda GA , ShanaiahN, CooperA, MaluccioM, RafteryD: Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer. Lipids44(1), 27–35 (2009).
  • Nagana Gowda GA , SomashekarBS, IjareOB, SharmaA, KapoorVK, KhetrapalCL: One-step analysis of major bile components in human bile using 1H NMR spectroscopy. Lipids41(6), 577–589 (2006).
  • Nagana Gowda GA , IjareOB, SomashekarBS, SharmaA, KapoorVK, KhetrapalCL: Single-step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy. Lipids41(6), 591–603 (2006).
  • Ijare OB , SomashekarBS, Nagana GowdaGA, SharmaA, KapoorVK, KhetrapalCL: Quantification of glycine and taurine conjugated bile acids in human bile using 1H NMR spectroscopy. Magn. Reson. Med.53(6), 1441–1446 (2005).
  • Srivastava M , JadegoudY, Nagana GowdaGA, SharmaA, KapoorVK, KhetrapalCL: An accurate method for cholesterol analysis in bile. Anal. Letts.38, 2135–2141 (2005).
  • Ijare OB , SomashekarBS, JadegoudY, Nagana GowdaGA: 1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media. Lipids40(10), 1031–1041 (2005).
  • Nagana Gowda GA , ShanaiahN, CooperA, MaluccioM, RafteryD: Bile acids conjugation in human bile is not random: new insights from 1H NMR spectroscopy at 800 MHz.Lipids (2009) (Epub ahead of print)
  • Khan SA , CoxIJ, ThillainayagamAV, BansiDS, ThomasHC, Taylor-RobinsonSD: Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer.Eur. J. Gastroenterol. Hepatol.17(7), 733–738 (2005).
  • Cox IJ , BellJD, PedenCJet al.: In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies.NMR Biomed.5(3), 114–120 (1992).
  • Cox IJ , MenonDK, SargentoniJet al.: Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.J. Hepatol.14(2–3), 265–275 (1992).
  • Francis IR , ChenevertTL, GubinBet al.: Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging.Radiology180(2), 341–344 (1991).
  • Glazer GM , SmithSR, ChenevertTLet al.: Image localized 31P magnetic resonance spectroscopy of the human liver.NMR Biomed.1(4), 184–189 (1989).
  • Albiin N , SmithIC, ArneloUet al.: Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.Acta Radiol.49(8), 855–862 (2008).
  • Somashekar BS , IjareOB, Nagana Gowda GA et al.: Analysis of bile and gallbladder tissue by NMR: A route for diagnosis of gallbladder cancer. Proc. Intl Soc. Mag. Reson. Med.15, 127 (2007)
  • Srivastava M , SharmaA, KapoorVK, Nagana GowdaGA: Stones from cancerous and benign gallbladders are different: a proton nuclear magnetic resonance spectroscopy study. Hepatol. Res.38(10), 997–1005 (2008).
  • Ijare OB , BezabehT, AlbiinNet al.: Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: a 1H MRS study.NMR Biomed. (Epub ahead of print) (2009).
  • Saxena V , GuptaA, Nagana GowdaGA, SaxenaR, YachhaSK, KhetrapalCL: 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed.19(5), 521–526 (2006).
  • Martínez-Granados B , MonleónD, Martínez-BisbalMCet al.: Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy.NMR Biomed.19(1), 90–100 (2006).
  • Bala L , TripathiP, BhattGet al.: 1H and 31P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection.NMR Biomed.22(2), 220–228 (2009).
  • Beger RD , SchnackenbergLK, HollandRD, LiD, DraganY: Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma.Metabolomics2(3), 125–134 (2006).
  • Kaplan O , KushnirT, AskenazyN, KnubovetsT, NavonG: Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.Cancer Res.57(8), 1452–1459 (1997).
  • Fang F , HeX, DengHet al.: Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis.Cancer Sci.98(11), 1678–1682 (2007).
  • Cho SG , LeeDH, LeeKYet al.: Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy.J. Comput. Assist. Tomogr.29(2), 163–169 (2005).
  • Chemin-Thomas C , EsclassanJ, PalevodyC, HollandeE: Characterization of a specific signal from human pancreatic tumors heterotransplanted into nude mice. Study by high resolution 1H NMR and HPLC.Int. J. Pancreatol.13(3), 175–185 (1993).
  • Bezabeh T , IjareOB, AlbiinN, ArneloU, LindbergB, SmithICP: 1H MRS of bile in the differential diagnosis of cholangiocarcinoma and pancreatic cancer.Proc. Intl Soc. Mag. Reson. Med.15, 3736 (2008).
  • Mal M , KohPK, CheahPY, ChanEC: Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue.Rapid Commun. Mass Spectrom.23(4), 487–494 (2008).
  • Denkert C , BudcziesJ, WeichertWet al.: Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover.Mol. Cancer7, 72 (2008).
  • Lean CL , NewlandRC, EndeDA, BokeyEL, SmithIC, MountfordCE: Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology.Magn. Reson. Med.30(5), 525–533 (1993).
  • Moreno A , ArúsC: Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies.NMR Biomed.9(1), 33–45 (1996).
  • Moreno A , ReyM, MontaneJM, AlonsoJ, ArúsC: 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance.NMR Biomed.6(2), 111–118 (1993).
  • Merchant TE , KasimosJN, de GraafPW, MinskyBD, GierkeLW, GlonekT: Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int. J. Colorectal Dis.6(2), 121–126 (1996).
  • Kasimos JN , MerchantTE, GierkeLW, GlonekT: 31P magnetic resonance spectroscopy of human colon cancer.Cancer Res.50(3), 527–532 (1990).
  • Merchant TE , DiamantisPM, LauwersGet al.: Characterization of malignant colon tumors with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles.Cancer76(10), 1715–1723 (1995).
  • Merchant TE , CharaciejusD, KasimosJN, Den OtterW, GierkeLW, GlonekT: Phosphodiesters in saponified extracts of human breast and colon tumors using 31P magnetic resonance spectroscopy. Magn. Reson. Med.26(1), 132–140 (1992).
  • Hakomori S , NudelmanE, LeverySB, KannagiR: Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain.J. Biol. Chem.259(7), 4672–4680 (1984).
  • Lean CL , MackinnonWB, MountfordCE: Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells.Magn. Reson. Med.20(2), 306–311 (1991).
  • Monleón D , MoralesJM, BarrasaA, LópezJA, VázquezC, CeldaB: Metabolite profiling of fecal water extracts from human colorectal cancer.NMR Biomed.22(3), 342–348 (2009).
  • Bezabeh T , SomorjaiRL, DolenkoBet al.: Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts.NMR Biomed. (Epub ahead of print) (2009).
  • Tadano T , KanohM, KondohHet al.: Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).Rinsho Byori.55(5), 417–427 (2007).
  • Tadano T , KanohM, MatsumotoM, SakamotoK, KamanoT: Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.Rinsho Byori.54(2), 103–110 (2006).
  • Bezabeh T , SmithIC, KrupnikEet al.: Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue.Anticancer Res.16(3B), 1553–1558 (1996).
  • Brière KM , KueselAC, BirdRP, SmithIC: 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats.NMR Biomed.8(1), 33–40 (1995).
  • Krupnik E , BrièreKM, BirdRP, LittmanC, SmithIC: 1H magnetic resonance spectroscopy evidence that aberrant crypt foci are preneoplastic lesions in the colon.Anticancer Res.19(3A), 1699–1703 (1999).
  • Calabrese C , PisiA, Di Febo G et al.: Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. Cancer Epidemiol. Biomarkers Prev.17(6), 1386–1395 (2008).
  • Buszewski B , UlanowskaA, LigorT, JackowskiM, KlodzinskaE, SzeligaJ: Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.868(1–2), 88–94 (2008).
  • Bennett A , CivierA, HensbyCN, MelhuishPB, StamfordIF: Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues.Gut28(3), 315–318 (1987).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.